prax: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	89,655	82,899
(decrease) increase in cash, cash equivalents and restricted cash	-65,845	-57,957
Cash and cash equivalents at beginning of period	215,788	-
Cash and cash equivalents at end of period	149,943	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	89,655	82,899
(decrease) increase in cash, cash equivalents and restricted cash	-65,845	-57,957
Cash and cash equivalents at beginning of period	215,788	-
Cash and cash equivalents at end of period	149,943	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Praxis Precision Medicines, Inc. (PRAX)